Wafergen Q3 Revenues More than Double | GenomeWeb

NEW YORK (GenomeWeb News) – Wafergen Biosystems today said that revenues in its third quarter more than doubled year over year.

For the three months ended Sept. 30, Wafergen's total revenues reached $389,547, up from $176,608 a year ago as the company took in $125,000 in license and royalty-related revenues in the quarter, compared to none a year ago. Product revenues increased to $264,547 from $176,608.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.